Greg B. Young

Greg joined Burrill & Company in 2000 and has been primarily involved in sourcing， evaluating and investing in new business opportunities as part of the firm’s venture activities. His focus areas of investment cover green technologies and businesses addressing energy， climate and sustainability markets. He also acts as an investment manager for the Malaysian Life Sciences Capital Fund （MLSCF）， a venture fund co-managed by Burrill & Company. Greg currently serves on the Board of HCL CleanTech and is a Board Observer on the Boards of Akermin and GloriOil. Greg was instrumental in sourcing and consummation of Burrill & Company and MLSCF’s investment in Gevo. Previously， Greg worked as a molecular biologist focused on protein expression at an early-stage biotech company located in San Diego. Greg received his BS in Biochemistry and Cell Biology from the University of California， San Diego and an MS in Biotechnology and Business from Northwestern University.